Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of sensitive skin type.

ITC Life Sciences Technology Centre0 个研究点目标入组 38 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1)Subjects with Fitzpatrick skin type III to V
•2)Sex: Males and non-pregnant/non-lactating females (preferably equal numbers of males and females).
•3)Subjects scoring greater than 30 for Section 2- Sensitive v/s Resistant skin in modified Dr. Baumannâ??s skin type questionnaire.
•4)Subjects identified to have sensitive skin on the basis of Dermatological assessment of skin with fine texture and closeness of blood vessels to the surface.

•1)Subjects who are pregnant or nursing (as confirmed by Urine Pregnancy Test for the determination of Pregnancy).
•2)Subjects under chronic medication (e.g. Antihistamines, Antifungals, Corticosteroids, topical Steroids, etc.) that might influence the outcome of the study.
•3)Subjects with cutaneous disease, chronic illness or self-reported Immunological disorders or any other illness including Diabetes, liver disease, HIV or any other serious medical illness.
•4)Subject suffering from any active clinically significant skin diseases which may contraindicate.
•5)Subjects with known allergy or sensitization to medical adhesives, bandages or a present condition of allergic response to any cosmetic product.

发起方

ITC Life Sciences Technology Centre